Loading…
Under pressure to catch the crooks: the impact of corporate privilege waivers on the adversarial system
Bristol-Myers Squibb also entered into a Deferred Prosecution Agreement in which it conceded that after the U.S. Attorney's Office for the District of New Jersey had commenced its investigation, the company made "significant personnel changes" that included replacing three key employe...
Saved in:
Published in: | The American criminal law review 2006-06, Vol.43 (3), p.1225 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Bristol-Myers Squibb also entered into a Deferred Prosecution Agreement in which it conceded that after the U.S. Attorney's Office for the District of New Jersey had commenced its investigation, the company made "significant personnel changes" that included replacing three key employees: the company's Chief Financial Officer, President of Worldwide Medicines Group and Controller.67 In addition, Bristol-Myers Squibb agreed to waive all claims of the attorney-client and work product protections with respect to its factual internal investigation and legal advice given contemporaneously with that investigation by the company's counsel. |
---|---|
ISSN: | 0164-0364 |